HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 1244379Erstellt: 25. Oktober 2026
Boron trifluoride etherate → HCID 21919258, Verbindung
https://huagongshe.com/reaction/1244379
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | Boron trifluoride etherate | HCID 8000 | — |
| Edukt | 1-Benzyl-4,4-diethoxypiperidin-3-amine | HCID 21729935 | — |
| Edukt | 4-Methoxy-7-morpholin-4-yl-benzothiazole-2-carboximidothioic acid methyl ester hydroiodide | HCID 69184072 | — |
| Lösungsmittel | Tetrahydrofuran | HCID 8028 | — |
| Produkt | HCID 21919258 | HCID 21919258 | 1% |
Reaktionsschritte
To a suspension of 0.04 g 4-methoxy-7-morpholin-4-yl-benzothiazole-2-carboximidothioic acid methyl ester hydroiodide in 1.8 ml tetrahydrofurane were added 0.1 g 1-benzyl-4,4-diethoxy-piperidin-3-ylamine in 1.8 ml tetrahydrofurane and the mixture was stirred at room temperature for 16 hours. Then 0.015 ml boron trifluoride etherate was added and the solvent was distilled off under vacuum. Again 0.015 ml boron trifluoride etherate was added and the mixture was dissolved in 1.5 ml dimethylformamide and heated for 15 minutes at 125° C. The solvent was distilled off and the residue was dissolved in dichloromethane and extracted with water. The organic layer was dried with sodium sulfate, filtered and the solvent was evaporated. Chromatography on silicagel with ethylacatate/heptane 1:1 to 2:1 yielded 0.4 mg (1%) 5-benzyl-2-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine as an amorphous solid; m/e=462 (M+H+).
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US07122545B2 |
|---|
| Quelldatensatz | uspto-grants-2006_10 |
|---|
| ORD ID | ord-11fac07d95c64a1cb1b38980ef5e47fc |
|---|
| Quellennotiz | uspto-grants-2006_10 |
|---|